HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

South Korea’s Health Ministry Takes Narrow View On OTC Sales, Limiting Products Like J&J’s Tylenol

This article was originally published in PharmAsia News

Executive Summary

After nearly two years of debate, South Korea’s health ministry will allow 13 OTC products to be sold in 24-hour convenience shops, but excludes most supermarkets.

You may also be interested in...



President Lee Nominates Competition-friendly Bureaucrat As New Health Minister

SEOUL - South Korea President Lee Myung-bak nominated a new minister of Health and Welfare in a partial cabinet shuffle Aug. 30, and his nominee is viewed as a market-oriented bureaucrat who could introduce foreign-friendly policies for Korea's healthcare market

Korea Allows Sales Of OTC Products In Supermarkets July 21, But Distribution Remains A Challenge

SEOUL - South Koreans are expected to be able to purchase 48 new over-the-counter products at supermarkets and conveniences stores, previously only available at pharmacies, beginning July 21, but consumers found that companies need more time to allow for the expanded distribution and manufacturing

Korea's Health Ministry Flip-Flops Again On OTC Drug Position; Now Seeks Expanded Consumer Access

SEOUL - Just a few days after South Korea's Ministry of Health and Welfare announced it would not allow sales of OTC drugs at supermarkets and convenience stores, the ministry is reversing its position, saying it will now push for a revision of Korea's drug law to allow sales of OTC products in the stores

Topics

Related Companies

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel